These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Efficacy and safety of tacrolimus in Osserman grade III and Osserman grade IV Myasthenia Gravis. Zhao LN; Liang Y; Fang XJ; Liu XM; Jiang QL; Wang SS; She SF; Cao M Clin Neurol Neurosurg; 2018 Oct; 173():70-76. PubMed ID: 30092406 [TBL] [Abstract][Full Text] [Related]
14. Rituximab in Myasthenia Gravis- Experience from a Low- and Middle-Income Country (LMIC) Setting. Shivaram S; Nagappa M; Varghese N; Seshagiri DV; Duble S; Siddappa SA; Hesarur N; Sinha S; Taly AB Neurol India; 2022; 70(5):1931-1941. PubMed ID: 36352590 [TBL] [Abstract][Full Text] [Related]
15. Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis. Solé G; Mathis S; Friedman D; Salort-Campana E; Tard C; Bouhour F; Magot A; Annane D; Clair B; Le Masson G; Soulages A; Duval F; Carla L; Violleau MH; Saulnier T; Segovia-Kueny S; Kern L; Antoine JC; Beaudonnet G; Audic F; Kremer L; Chanson JB; Nadaj-Pakleza A; Stojkovic T; Cintas P; Spinazzi M; Foubert-Samier A; Attarian S Neurology; 2021 Apr; 96(16):e2109-e2120. PubMed ID: 33568541 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of telitacicept for refractory generalized myasthenia gravis: a retrospective study. Lin J; Li Y; Gui M; Bu B; Li Z Ther Adv Neurol Disord; 2024; 17():17562864241251476. PubMed ID: 38751755 [TBL] [Abstract][Full Text] [Related]
18. [Distribution characteristics and correlation analysis of antibody detection value in myasthenia gravis]. Liu YL; Zheng YM; Luo JJ; Zhang W; Gao F; Yuan Y; Hao HJ Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(41):3221-3226. PubMed ID: 31694116 [No Abstract] [Full Text] [Related]